PARIS (Reuters) The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday. FILE PHOTO: A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo They said [ ] The post European Medicines Agency to review Sanofi-Regeneron s Dupixent, Cemiplimab appeared first on Health and Fitness.
http://bit.ly/2uMS8uC
没有评论:
发表评论